title: Pulling the trigger on the tumor's bodyguards: what puts Tregs out of action?
authors.forename: Jens
authors.initials: J
authors.lastname: Nolting
authors.forename: Peter
authors.initials: P
authors.lastname: Brossart
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D018925:Chemokines / Q000378:metabolism; D051858:Forkhead Transcription Factors / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007376:Interleukin-2 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008212:Lymphocyte Depletion / Q000379:methods; D009369:Neoplasms / Q000276:immunology* / Q000378:metabolism; D053245:RANK Ligand / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000166:cytology / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D051193:Toll-Like Receptors / Q000378:metabolism; D053782:Transforming Growth Factor beta3 / Q000378:metabolism; D019139:Tumor Escape / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D018925:Chemokines; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D007376:Interleukin-2; D015850:Interleukin-6; D053245:RANK Ligand; D051193:Toll-Like Receptors; D053782:Transforming Growth Factor beta3